Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 40/100

Failure Rate

13.0%

3 terminated/withdrawn out of 23 trials

Success Rate

82.4%

-4.1% vs industry average

Late-Stage Pipeline

43%

10 trials in Phase 3/4

Results Transparency

43%

6 of 14 completed trials have results

Key Signals

6 with results

Enrollment Performance

Analytics

Phase 4

10(47.6%)

N/A

8(38.1%)

Phase 2

3(14.3%)

21Total

Phase 4(10)

N/A(8)

Phase 2(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (23)

Showing 20 of 23 trials

NCT03321604Terminated

Kidney Information Network for Disease Research and Education

Role: collaborator

NCT01000675Completed

Registry for Study of Coils in Intracranial Aneurysms

Role: collaborator

NCT00138294Phase 4Completed

Control of Epidemic Influenza Through a School-based Influenza Vaccination Program

Role: collaborator

NCT00611208Phase 2Completed

A-dmDT390-bisFv(UCHT1) Immunotoxin Therapy for Patients With Cutaneous T-Cell Lymphoma (CTCL)

Role: collaborator

NCT02943642Phase 2Unknown

Safety and Effectiveness of A-dmDT390-bisFv(UCHT1) Fusion Protein in Subjects With Mycosis Fungoides

Role: collaborator

NCT01346839Not ApplicableCompleted

Effectiveness of Electronic Health Record-Based Interventions for Improving Follow-Up in Primary Care

Role: collaborator

NCT02639039Phase 4Completed

Cortisone Injection vs Trigger Point Dry Needling Fin the Treatment of Greater Trochanter Pain Syndrome: A Pilot Study

Role: lead

NCT00803140Not ApplicableTerminated

Cutaneous Scarring of Scalpel Versus Cautery

Role: lead

NCT00738621Phase 4Completed

Combination Antiemetic Regimen for Prevention of PONV in Breast Surgery Patients

Role: lead

NCT01221090Phase 4Completed

Diabetes Self-Management Models to Reduce Health Disparities

Role: lead

NCT00094133Not ApplicableUnknown

Hypnosis in Treating Hot Flashes in Breast Cancer Survivors

Role: lead

NCT00726713Phase 4Completed

Study of Metanx® in Subjects With Type 2 Diabetic Peripheral Neuropathy (DPN)

Role: collaborator

NCT01570634Phase 2Terminated

Proof-of-Concept, Calcium Aluminosilicate Anti-Diarrheal (CASAD) for Treatment of Clostridium Difficile Infection

Role: collaborator

NCT01792206Not ApplicableUnknown

Effect Of Paricalcitol (Zemplar) On Endothelial Function And Inflammation In Type 2 Diabetes And Chronic Kidney Disease

Role: lead

NCT01243112Phase 4Completed

Effectiveness Study of Different Local Anesthetic Mixtures

Role: lead

NCT00475189Not ApplicableCompleted

Study of Loestrin 24(24 Days of "Real" Pills) Fe Versus Loestrin 1/20 (21 "Real" Pills)

Role: lead

NCT00700128Not ApplicableCompleted

Prevention of Menstrual Migraines: Using Frovatriptan or Placebo During Hormone Free Intervals

Role: lead

NCT01391052Phase 4Unknown

Pretreatment With Norethindrone Acetate Prior to Levonorgestrel IUS Insertion for Heavy Menstrual Bleeding

Role: lead

NCT01218269Phase 4Completed

U-clip Pilot Study in Plastic Surgery

Role: lead

NCT01251263Phase 4Unknown

Prevention of Menstrual Migraines: Effects of Estrogen Add-back During the HFI in Patients Using Continuous Oral Contraceptives.

Role: lead